Ricardo Rodriguez Aponte, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Calle Jose C Vazquez, Aibonito, PR 00705 Phone: 787-735-0040 Fax: 787-735-0041 |
Karla Marie Rodriguez Tirado, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 165 Calle Baldorioty N, Aibonito, PR 00705 Phone: 787-694-3202 |
Rafael Luis Marrero, M.D. Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: Calle Pedro Rosario Num.20, Edificio Aibonito Plaza Suite C, Aibonito, PR 00705 Phone: 787-735-1075 Fax: 787-735-5572 |
Dr. Rexie Navarro Gonzalez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Clinicas Externas Hospital Menonita Aibonito, Calle Dr Troyer A3 Villa Rosales, Aibonito, PR 00705 Phone: 787-299-0963 Fax: 787-735-7111 |
Dr. Maria Mercedes Martinez Ortiz, 09/26/1968 Family Medicine Medicare: Medicare Enrolled Practice Location: Street 722 Km 6.9, Aibonito, PR 00705 Phone: 787-991-0934 Fax: 787-991-0934 |
Nancy Torres-torres, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Calle Julio Cintron, Edificio Guayacan Suite 218, Aibonito, PR 00705 Phone: 787-384-2387 |
News Archive
Mothers have been telling their children to stop slouching for ages. It turns out that mom was onto something and that poor posture not only makes a bad impression, but can actually make you physically weaker. According to a study by Scott Wiltermuth, assistant professor of management organization at the USC Marshall School of Business, and Vanessa K. Bohns, postdoctoral fellow at the J.L. Rotman School of Management at the University of Toronto, adopting dominant versus submissive postures actually decreases your sensitivity to pain.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced it has completed enrollment in its ongoing 200-patient Phase 2b study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.
The study of children's interactions with robots was carried out at the Norwegian research fair held in every major city. It is an annual national event where children gain insight into science and what researchers do.
› Verified 6 days ago